Aki Kuroki

803 citations
31 papers · 502 indexed · h-index 13
Topics
Renal Diseases and Glomerulopathies (12 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Vasculitis and related conditions (6 papers)

In The Last Decade

Aki Kuroki

31 papers receiving 494 citations

Peers

Aki Kuroki
Comparison fields: 5 of 65
  • Nephrology 273
  • Molecular Biology 142
  • Immunology 130
  • Pulmonary and Respiratory Medicine 121
  • Rheumatology 103
Replace Pj Hoedemaeker with:
Pj Hoedemaeker Netherlands
D F Woodrow United Kingdom
Masashi Aizawa Japan
J. Berger Germany
Pieter van der Pol Netherlands
Daniëlle J. van Gijlswijk‐Janssen Netherlands
Matthieu Mahévas France
Fanny Tabarin France
Manuela Colucci Italy
Margaret A. Reisberg United States
Aki Kuroki relative to Pj Hoedemaeker Netherlands Pj Hoedemaeker's profile →
Citations per field
00.5×10×15×22×
Pj Hoedemaeker · 1×
Citations per year

Countries citing papers authored by Aki Kuroki

Since Specialization
Citations

This map shows the geographic impact of Aki Kuroki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aki Kuroki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aki Kuroki more than expected).

Fields of papers citing papers by Aki Kuroki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aki Kuroki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aki Kuroki. The network helps show where Aki Kuroki may publish in the future.

Co-authorship network of co-authors of Aki Kuroki

This figure shows the co-authorship network connecting the top 25 collaborators of Aki Kuroki. A scholar is included among the top collaborators of Aki Kuroki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aki Kuroki. Aki Kuroki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 19
2 4
3 27
4 12
5 13
6 2
7
[Drug-induced nephrotic syndrome].
2
8 9
9 8
10 15
11 1
12 96
13 37
14 2
15 4
16 10
17 20
18 22
19 100
20 5

About Aki Kuroki

Aki Kuroki is a scholar working on Nephrology, Hematology and Rheumatology, having authored 31 papers that have together received 502 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (12 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Vasculitis and related conditions (6 papers). The work is most often cited by research in Nephrology (273 citations), Rheumatology (103 citations) and Immunology (130 citations). Aki Kuroki has collaborated with scholars based in Japan, Switzerland and United States. Frequent co-authors include Tetsuzo Sugisaki, Takanori Shibata, Masayuki Iyoda, Hirokazu Honda, Kenji Kobayashi, Shozo Izui, Shuichi Kikuchi, Tadao Akizawa, Liliane Fossati‐Jimack and Munehiro Nakata. Their work appears in journals such as Blood, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026